Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 13 hot stocks to buy with the highest upside potential. On January 30, Stifel raised its price target on Crinetics Pharmaceuticals Inc.

Management projects consolidated net sales growth of 4% at the midpoint for fiscal 2026, based on current guidance and strategic execution priorities. Brand contribution -- Sales growth in the coming ...

The billionaire tech mogul's testimony was part of a landmark social media addiction trial in Los Angeles. The jury's verdict ...

Arrae doesn’t launch supplements like a wellness brand, it launches them like a fashion house. Now an over $100M business, co ...

The CEO laid out the fiscal 2026 operating strategy, including expansion of omnichannel reach, product launches, technology modernization, Hiya's direct-to-consumer and retail growth, and scaling Rise ...

The cult-favorite grocer is teaming up with high-tech wellness startup Function to launch "the world's healthiest smoothie," a yearlong collab that aims to rethink what "healthy" actually means.

Discover if higher pay or better benefits lead to smarter job decisions. Learn the value of benefits like healthcare, remote work, and retirement options.

Target has issued multiple recalls so far in 2026, affecting children’s products, household items, and food sold in its ...

The father of a North Providence High School senior shot five members of the student's family at a hockey game Monday, ...

Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are ...

The surge in anti-LGBTQ+ legislation aligns with nationwide efforts fueled by groups like the Heritage Foundation and the ...